Page last updated: 2024-08-26

bosentan anhydrous and Breast Neoplasms

bosentan anhydrous has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clemens, MG; Culberson, C; Dréau, D; Karaa, A; McKillop, IH; Wyan, H	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Breast Neoplasms

Article	Year
Bosentan inhibits tumor vascularization and bone metastasis in an immunocompetent skin-fold chamber model of breast carcinoma cell metastasis. Clinical & experimental metastasis, 2006, Volume: 23, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Bone Neoplasms; Bosentan; Breast Neoplasms; Cell Division; Endothelin-1; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Biological; Neoplasm Metastasis; RNA, Messenger; Skin; Sulfonamides	2006

Article

Year

Bosentan inhibits tumor vascularization and bone metastasis in an immunocompetent skin-fold chamber model of breast carcinoma cell metastasis.

Clinical & experimental metastasis, 2006, Volume: 23, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Bone Neoplasms; Bosentan; Breast Neoplasms; Cell Division; Endothelin-1; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Biological; Neoplasm Metastasis; RNA, Messenger; Skin; Sulfonamides

2006